PSA: Declining Utilization of Brachytherapy for the Treatment of Prostate Cancer

被引：0
|
作者：
Andring, Lauren [1 ]
Pezzi, Todd A. [2 ]
Tang, Chad [1 ]
Walker, Gary [3 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Banner Hlth, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2021年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P045
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [21] HDR brachytherapy as monotherapy in the treatment of prostate cancer
    Komina, Oxana
    Seitz-Kaestner, Christine
    Pajer, Thomas
    Kohl, Bettina
    Hummel, Johann
    Knocke-Abulesz, Tomas-Hendrik
    Nechvile, Elisabeth
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S402 - S403
  • [22] Clinical, treatment, and dosimetric parameters predictive of prostate specific antigen (PSA) spikes following prostate brachytherapy
    Butler, W
    Merrick, G
    Lief, J
    Galbreath, R
    MEDICAL PHYSICS, 2003, 30 (06) : 1467 - 1467
  • [23] Interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer
    Machtens, S
    Karstens, JH
    Baumann, R
    Jonas, U
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (06) : 514 - 521
  • [24] Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
    Galego, Pedro
    Silva, Fernando C.
    Pinheiro, Luis Campos
    INTERNATIONAL BRAZ J UROL, 2015, 41 (02): : 353 - 359
  • [25] Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers
    Todd Morgan
    Ganesh Palapattu
    John Wei
    Current Urology Reports, 2015, 16
  • [26] The Rise and Fall of Prostate Brachytherapy: Use of Brachytherapy for the Treatment of Localized Prostate Cancer in the National Cancer Data Base
    Martin, Jeffrey M.
    Handorf, Elizabeth A.
    Kutikov, Alexander
    Uzzo, Robert G.
    Bekelman, Justin E.
    Horwitz, Eric M.
    Smaldone, Marc C.
    CANCER, 2014, 120 (14) : 2114 - 2121
  • [27] Clinical implication of PSA bounce after treatment of prostate cancer with brachytherapy and/or external beam radiotherapy with or without androgen deprivation
    Antonucci, JV
    Fitch, DL
    Vargas, CE
    Boike, T
    Byrd, C
    Gustafson, GS
    Martinez, AA
    Vicini, FA
    Kestin, LL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S301 - S301
  • [28] Definitions of biochemical control after permanent interstitial brachytherapy as sole treatment for localized prostate cancer: Interpreting the PSA bounce
    Coen, JJ
    Zietman, AL
    Grocela, JA
    Heney, NM
    Babayan, RK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S444 - S444
  • [29] Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy
    Yoichiro Yamamoto
    Chetan P Offord
    Go Kimura
    Shigehiko Kuribayashi
    Hayato Takeda
    Shinichi Tsuchiya
    Hisashi Shimojo
    Hiroyuki Kanno
    Ivana Bozic
    Martin A Nowak
    Željko Bajzer
    David Dingli
    British Journal of Cancer, 2016, 115 : 195 - 202
  • [30] PSA-based vaccines for the treatment of prostate cancer
    Madan, Ravi A.
    Gulley, James L.
    Arlen, Philip M.
    EXPERT REVIEW OF VACCINES, 2006, 5 (02) : 199 - 209
12345